We are live on ! Find out more
IRD

Opus Genetics
IRD

50 hedge funds and large institutions have $11.3M invested in Opus Genetics in 2023 Q4 according to their latest regulatory filings, with 12 funds opening new positions, 13 increasing their positions, 9 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

3,525% more call options, than puts

Call options by funds: $435K | Put options by funds: $12K

44% more repeat investments, than reductions

Existing positions increased: 13 | Existing positions reduced: 9

2% more funds holding

Funds holding: 49 → 50 (+1)

9% more first-time investments, than exits

New positions opened: 12 | Existing positions closed: 11

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

1.22% less ownership

Funds ownership: 17.87% → 16.65% (-1.2%)

10% less capital invested

Capital invested by funds: $12.6M → $11.3M (-$1.23M)

Holders
50
Holders Change
+1
Holders Change %
+2.04%
% of All Funds
0.73%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.01%
New
12
Increased
13
Reduced
9
Closed
11
Calls
$435K
Puts
$12K
Net Calls
+$423K
Net Calls Change
+$264K

Top Buyers

Rank Fund Capital Flow
1
BCM
Bridgeway Capital Management
Texas
+$390K
2
Millennium Management
Millennium Management
New York
+$254K
3
Morgan Stanley
Morgan Stanley
New York
+$245K
4
Vanguard Group
Vanguard Group
Pennsylvania
+$204K
5
AFM
Anson Funds Management
Texas
+$146K

Top Sellers

Rank Fund Capital Flow
1
RHJA
Rice Hall James & Associates
California
-$759K
2
RB
Richmond Brothers
Michigan
-$341K
3
MCM
MAI Capital Management
Ohio
-$189K
4
Acadian Asset Management
Acadian Asset Management
Massachusetts
-$165K
5
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$99.9K
Name Holding Trade Value Shares
Change 		Change in
Stake
Susquehanna International Group
26
Susquehanna International Group
Pennsylvania
$66.8K -$99.9K -33,795 -60%
CAPTRUST Financial Advisors
27
CAPTRUST Financial Advisors
North Carolina
$54.2K – – –
Osaic Holdings
28
Osaic Holdings
Arizona
$52.1K -$12.5K -4,225 -20%
Royal Bank of Canada
29
Royal Bank of Canada
Ontario, Canada
$47K +$683 +231 +1%
Citadel Advisors
30
Citadel Advisors
Florida
$46K +$45.2K +15,275 New
BFC
31
Bedel Financial Consulting
Indiana
$45.1K – – –
Prudential Financial
32
Prudential Financial
New Jersey
$40.3K +$39.6K +13,400 New
SFO
33
Stokes Family Office
Louisiana
$36.5K -$2.69K -910 -7%
UBV
34
United Bank (Virginia)
Virginia
$35.5K – – –
LNC
35
Lincoln National Corp
Pennsylvania
$35.2K – – –
Simplex Trading
36
Simplex Trading
Illinois
$30K +$7.17K +2,424 +32%
UBS Group
37
UBS Group
Switzerland
$16.2K +$16K +5,398 New
Wells Fargo
38
Wells Fargo
California
$8.88K +$27 +9 +0.3%
National Bank of Canada
39
National Bank of Canada
Quebec, Canada
$6.12K – – –
CFGS
40
Concourse Financial Group Securities
Alabama
$3.56K – – –
TFA
41
Toth Financial Advisory
Virginia
$3.01K – – –
CWM
42
CarsonAllaria Wealth Management
Illinois
$3.01K – – –
OIA
43
Optimum Investment Advisors
Illinois
$3.01K – – –
Group One Trading
44
Group One Trading
Illinois
$2.13K -$4.7K -1,589 -69%
NS
45
NBC Securities
Alabama
$1K – – –
IGWM
46
ICA Group Wealth Management
Colorado
$90 +$89 +30 New
RhumbLine Advisers
47
RhumbLine Advisers
Massachusetts
$87 – – –
Bank of America
48
Bank of America
North Carolina
$81 +$80 +27 New
NA
49
NewEdge Advisors
Louisiana
$57 +$56 +19 New
Acadian Asset Management
50
Acadian Asset Management
Massachusetts
– -$165K -49,563 Closed
1
2
3

IRD Hedge Fund Activity: Q4 2023 in Review

50 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in Opus Genetics (IRD) for Q4 2023, worth a combined $11.3M — down 9.8% from $12.6M a quarter earlier.

Buyers outnumbered sellers: 12 funds opened new IRD positions and 11 closed out — a net gain of 1 holder — while 13 added to existing stakes and 9 trimmed.

The largest buyer was Bridgeway Capital Management, adding an estimated $390K. The largest seller was Rice Hall James & Associates, cutting an estimated $759K.

  • 50 institutional investors held Opus Genetics (IRD) as of Q4 2023, up from 49 in Q3 2023.
  • Funds reported $11.3M of Opus Genetics stock for Q4 2023, down 9.8% quarter-over-quarter.
  • 12 funds opened new Opus Genetics positions in Q4 2023 and 11 closed out, a net change of +1 holder.
  • The largest Opus Genetics buyer in Q4 2023 was Bridgeway Capital Management, an estimated $390K added.
  • The largest Opus Genetics seller in Q4 2023 was Rice Hall James & Associates, an estimated $759K sold.

Based on aggregated 13F filings for Q4 2023.